GIUSEPPE DI BELLA
>
DOCUMENTATION INDEX > Patient Area - Documents
Visualization of somatostatin receptors in prostate cancer and its bone metastases with Ga-68-DOTATOC PET/CT.
(12/04/2011)
Detail
Octreotide inhibits growth of colonic cancer SW480 cells by modulating the Wnt/P-catenin pathway.
(12/04/2011)
Detail
Peptide receptor radionuclide therapy with (90)Y-DOTATOC in recurrent meningioma.
(12/04/2011)
Detail
Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue.
(12/04/2011)
Detail
Treatment of advanced hepatocellular carcinoma with long-acting octreotide: a phase III multicentre, randomised, double blind placebo-controlled study.
(12/04/2011)
Detail
(90)Yttrium-DOTA]-TOC response is associated with survival benefit in iodine-refractory thyroid cancer: long-term results of a phase 2 clinical trial.
(12/04/2011)
Detail
Radiological imaging change in a malignant bowel obstruction patient treated with octreotide.
(12/04/2011)
Detail
Somatostatin receptor expression in thymic tumors.
(12/04/2011)
Detail
Highlights of regional meeting of Italian Southern Oncological Group (GOIM): focus on hepatocellular carcinoma: biological and clinical background, therapeutic guide-lines and perspectives.
(12/04/2011)
Detail
Regulation of growth factors in hormone- and drug-resistant prostate cancer cells by synergistic combination of docetaxel and octreotide.
(12/04/2011)
Detail
Malignant irreversible intestinal obstruction: the powerful association of octreotide to corticosteroids, antiemetics, and analgesics.
(12/04/2011)
Detail
Octreotide uptake in intracranial metastasis of pancreatic ductal adenocarcinoma origin in a patient with a prolonged clinical course.
(12/04/2011)
Detail
Paclitaxel-octreotide conjugates in tumor growth inhibition of A549 human non-small cell lung cancer xenografted into nude mice.
(12/04/2011)
Detail
Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro.
(12/04/2011)
Detail
Assessment of tumor volumes in skull base glomus tumors using Gluc-Lys[(18)F]-TOCA positron emission tomography.
(12/04/2011)
Detail